Tirzepatide (Mounjaro) is the newest diabetes drug in 2024, combining two hormones to lower blood sugar and promote weight loss. It outperforms older meds like Ozempic and is now available on the NHS in the UK for eligible patients.
Read MoreBy Rahul Chatterjee | 0 Comments | February 27, 2026
Tirzepatide (Mounjaro) is the newest diabetes drug in 2024, combining two hormones to lower blood sugar and promote weight loss. It outperforms older meds like Ozempic and is now available on the NHS in the UK for eligible patients.
Read MoreLearn how to start an ayurvedic diet with simple, practical steps based on your body type. Focus on digestion, timing, and mindful eating-not restriction. Feel lighter, clearer, and more balanced in just days.
Wondering how long you'll stay in hospital after heart surgery? Find specific stats, recovery tips and what impacts stay length with real-life insights and facts.
Dysthymia, a persistent depressive disorder, often flies under the radar despite its profound impact on everyday life. Characterized by a chronic low mood lasting for years, it can be misinterpreted as mere pessimism or a negative outlook. Unlike episodic depression, dysthymia subtly infiltrates day-to-day living, making it challenging to diagnose and often goes untreated. Increasing awareness and understanding of dysthymia’s symptoms is crucial for proper diagnosis and therapy.
The #1 secret to weight loss isn't calorie counting or extreme diets-it's fixing your hormones, eating whole foods, and building habits that last. Discover what really works.
Looking for top-notch medical treatment abroad? Discover which country is leading the charge in healthcare excellence. This article explores why some nations excel in medical services and what factors contribute to their global reputation. Whether it's advanced technology, skilled professionals, or cost-effectiveness, find out what makes these countries stand out. Get practical tips on making the most of your medical journey.